Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs propofol + low-dose ketamine for prevention of post-extubation cough and laryngospasm
TCTR20191125001Phase 4Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cough and laryngismus comparing Propofol alone with Propofol + low-dose ketamine (2 arms). Primary endpoints: Incidence of post-extubation cough and Incidence of laryngospasm. Started Nov 2018; status: completed.
02
Drugs
propofolketamine
03
Conditions
coughlaryngismus
Beyond the preview
Go deeper on TCTR20191125001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191125001.